Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation
Authors:
Open Access
- 1 January 2014
- journal article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 11 (3) , 268-275
Abstract
Background: Metastasis-associated in colon cancer-1 (MACC1) acts as a promoter of tumor metastasis; however, the predictive value of MACC1 for hepatocellular carcinoma (HCC) after liver transplantation (LT) remains unclear.Keywords
This publication has 33 references indexed in Scilit:
- Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinomaWorld Journal of Gastroenterology, 2012
- Identification of MACC1 as a novel prognostic marker in hepatocellular carcinomaJournal of Translational Medicine, 2011
- Molecular signature for HCC: role in predicting outcomes after liver transplant and selection for potential adjuvant treatmentCurrent Opinion in Organ Transplantation, 2010
- Cancer gene discovery in hepatocellular carcinomaJournal of Hepatology, 2010
- Targeting the HGF/Met signalling pathway in cancerEuropean Journal of Cancer, 2010
- Molecular mechanisms of hepatocellular carcinomaHepatology, 2008
- Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markersJournal of Hepatology, 2008
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJournal of Clinical Investigation, 2006
- HGF induces FAK activation and integrin-mediated adhesion in MTLn3 breast carcinoma cellsInternational Journal of Cancer, 1999